By Finance Pulse in RAPT —

Rapt Therapeutics Upgraded to Buy by H.C. Wainwright

Rapt Therapeutics sees a positive upgrade to Buy by H.C. Wainwright following a new licensing agreement for its lead product, boosting investor confidence.

A stylized image featuring a stock market graph trending upwards with Rapt Therapeutics' logo subtly
Rapt Therapeutics Upgraded to Buy by H.C. Wainwright

Rapt Therapeutics was upgraded to Buy by H.C. Wainwright due to a new licensing agreement.

Source